On the basis of this observation, mTOR inhibitors including sirolimus, everolimus, and temsirolimus, have been used in the treatment of PEComas with good clinical results as reported mostly in retrospective reviews and case reports (9–15). This evidence concerns the gene MTOR and neoplasm with perivascular epithelioid cell differentiation.